Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-094121
Filing Date
2025-07-03
Accepted
2025-07-03 20:36:07
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7531
  Complete submission text file 0000950170-25-094121.txt   8985
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Issuer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CORCEPT THERAPEUTICS INCORPORATED 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address
Lyon Joseph Douglas (Reporting) CIK: 0001817838 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50679 | Film No.: 251106816